SI2066349T1 - Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih - Google Patents

Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih

Info

Publication number
SI2066349T1
SI2066349T1 SI200730948T SI200730948T SI2066349T1 SI 2066349 T1 SI2066349 T1 SI 2066349T1 SI 200730948 T SI200730948 T SI 200730948T SI 200730948 T SI200730948 T SI 200730948T SI 2066349 T1 SI2066349 T1 SI 2066349T1
Authority
SI
Slovenia
Prior art keywords
transplantation
tumors
antibodies
treatment
autoimmune diseases
Prior art date
Application number
SI200730948T
Other languages
English (en)
Inventor
Melissa Damschroder
Peter Kiener
Herren Wu
Acqua William Dall
Ronald Herbst
Anthony Coyle
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Priority claimed from PCT/US2007/077916 external-priority patent/WO2008031056A2/en
Publication of SI2066349T1 publication Critical patent/SI2066349T1/sl

Links

SI200730948T 2006-09-08 2007-09-07 Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih SI2066349T1 (sl)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US84293506P 2006-09-08 2006-09-08
US86691706P 2006-11-22 2006-11-22
US91139707P 2007-04-12 2007-04-12
US91530907P 2007-05-01 2007-05-01
US93942907P 2007-05-22 2007-05-22
PCT/US2007/077916 WO2008031056A2 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
EP07842083A EP2066349B1 (en) 2006-09-08 2007-09-07 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases

Publications (1)

Publication Number Publication Date
SI2066349T1 true SI2066349T1 (sl) 2012-08-31

Family

ID=41104973

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200730948T SI2066349T1 (sl) 2006-09-08 2007-09-07 Humanizirana anti-cd19 protitelesa in njihova uporaba v zdravljenju tumorjev, transplantacijah in avtoimunih boleznih

Country Status (3)

Country Link
CN (1) CN101534859B (sl)
CY (1) CY2022028I2 (sl)
SI (1) SI2066349T1 (sl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016246698B2 (en) * 2015-04-06 2022-06-02 Regeneron Pharmaceuticals, Inc. Humanized T cell mediated immune responses in non-human animals
CN117024588A (zh) * 2016-09-06 2023-11-10 华道(上海)生物医药有限公司 抗cd19抗体在制备白血病治疗药物中的用途
CN106599593B (zh) * 2016-12-22 2019-03-26 贵州源熙生物研发有限公司 一种天然抗癌肽的改造方法
US11634488B2 (en) 2017-07-10 2023-04-25 International—Drug—Development—Biotech Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics
BR112021020924A2 (pt) * 2019-04-24 2022-04-19 Viela Bio Inc Uso de um anticorpo anti-cd19 para tratar doença autoimune
CN112578117B (zh) * 2021-02-22 2021-05-25 信纳克(北京)生化标志物检测医学研究有限责任公司 抗体组合物及其筛查移植后淋巴细胞增殖性疾病的应用
CN114349863B (zh) * 2022-03-21 2022-07-12 上海优替济生生物医药有限公司 一种抗cd19抗体及其制备方法和用途
CN116516007B (zh) * 2023-04-18 2024-01-19 华中科技大学同济医学院附属协和医院 Cd19表达的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2534639C (en) * 2003-07-31 2013-07-30 Immunomedics, Inc. Anti-cd19 antibodies
AU2006214121B9 (en) * 2005-02-15 2013-02-14 Duke University Anti-CD19 antibodies and uses in oncology

Also Published As

Publication number Publication date
CY2022028I1 (el) 2023-01-05
CN101534859B (zh) 2017-06-09
CY2022028I2 (el) 2023-01-05
CN101534859A (zh) 2009-09-16

Similar Documents

Publication Publication Date Title
EP1998799A4 (en) HUMANIZED ANTIBODIES AGAINST CD22 ANTIGEN AND THEIR USE FOR THERAPEUTIC USE IN ONCOLOGY, TRANSPLANTATION AND AUTOIMMUNE DISEASES
EP2068925A4 (en) ANTI-ICOS ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER, TRANSPLANTATIONS AND AUTOIMMUNE DISEASES
EP1999148A4 (en) HUMANIZED ANTI-CD22 ANTIBODIES AND THEIR USE IN ONCOLOGY TREATMENT, TRANSPLANTATION AND AUTOIMMUNE DISEASE
HK1223114A1 (zh) 抗因子 單克隆抗體及其使用方法
EP2091975A4 (en) ANTIBODIES TO THE EGFR FAMILY, BICE-SPECIFIC ANTIBODIES TO THE EGFR FAMILY AND METHOD FOR THEIR USE
CY2022028I1 (el) Εξανθρωπισμενα αντισωματα αντι-cd19 και οι χρησεις τους στην θεραπεια ογκων, μεταμοσχευσης και ασθενειων αυτο-ανοσιας
IL231169A0 (en) Human monoclonal antibodies to fucosil - 1gm and methods of using antibodies against fucosil - 1gm
EP2103628A4 (en) MONOCLONAL ANTIBODY ANTI-CLAUDIN 3, AND TREATMENT AND DIAGNOSIS OF CANCER USING SUCH ANTIBODY
IL188591A0 (en) Methods of treating autoimmune disease using humanized anti-cd16a antibodies
EP2021029A4 (en) HUMANIZED FC RIB SPECIFIC ANTIBODIES AND METHOD FOR THEIR USE
IL196914A0 (en) Variable region sequences of il-31 monoclonal antibodies and methods of use
IL225386A0 (en) Diagnosis and treatment of cancer using anti-ereg antibody
EP1793858A4 (en) HUMAN MONOCLONAL ANTI-CTLA4 ANTIBODIES FOR CANCER TREATMENT
IL200610A0 (en) Human monoclonal anti-ip-10 antibodies and uses thereof
EP2347038A4 (en) METHOD FOR HUMANIZATION AND AFFINITY TREATMENT OF ANTIBODIES
EP2050466A4 (en) DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-DESMOGLEIN ANTIBODY-3
IL205866A (en) Human or human antibodies against nkg2d, a method of manufacture and use thereof for drug preparation
HK1163119A1 (en) Anti cxcr4 antibodies and their use for the treatment of cancer cxcr4
EP2216344A4 (en) DIAGNOSIS AND TREATMENT OF CANCER WITH AN ANTI-GPR49 ANTIBODY
IL193604A0 (en) Methods of using antibodies against human il-22
ZA200902419B (en) Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
EP1998807A4 (en) METHODS OF HUMANIZING ANTIBODIES AND HUMANIZED ANTIBODIES THUS OBTAINED
WO2010054377A3 (en) Fully human antibodies against n-cadherin
EP2185718A4 (en) HUMAN MONOCLONAL ANTIBODIES AND METHOD FOR THEIR MANUFACTURE
EP2123676A4 (en) DIAGNOSIS AND TREATMENT OF CANCER USING ANTI-PRG-3 ANTIBODIES